INTERNATIONAL PATENT: BRIACELL THERAPEUTICS CORP. FILES APPLICATION FOR "CANCER VACCINES EXPRESSING POST-TRANSLATIONAL MODIFIED ANTIGENS AND METHODS OF USE THEREOF"

GENEVA, Aug. 19 -- BRIACELL THERAPEUTICS CORP. (2929 Arch Street, 3rd FloorPhiladelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/014759) for "CANCER VACCINES EXPRESSING POST-TRANSLATIONAL MODIFIED ANTIGENS AND METHODS OF USE THEREOF" on Feb 06, 2025. With publication no. WO/2025/171109, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WILLIAMS, William V. (c/o BriaCell Therapeutics Corp.2929 Arch Street, 3rd FloorPhiladelphia, Pennsylvania 19104), LOPEZ-LAGO, Miguel (c/o BriaCell Therapeutics Corp.2929 A...